Anti-Obesity Drugs Market is expected to reach US$ 5.95 Bn by 2030 from US$ 2.22 Bn in 2023, at a CAGR of 15.1% during the forecast period.
What is Anti-Obesity Drugs Market scope and Research Methodology ?
The Anti-Obesity Drugs Market focuses on medications developed to assist in weight management and obesity treatment, targeting a growing global issue driven by lifestyle factors and related health conditions like diabetes and cardiovascular disease. The market scope includes prescription drugs, over-the-counter medications, and novel therapeutics aimed at reducing body weight by curbing appetite or altering metabolic functions.
The research methodology for analyzing this market combines primary research, such as interviews with healthcare professionals and pharmaceutical experts, and secondary research, including the review of clinical trials, regulatory approvals, and Anti-Obesity Drugs Market industry reports. This method helps provide a comprehensive view of market trends, drug efficacy, competitive landscape, and growth opportunities in the anti-obesity drug sector.
Download a Free PDF Sample of the Report: Full TOC, Tables, Figures & Charts Included:https://www.maximizemarketresearch.com/request-sample/100768/
What are Anti-Obesity Drugs Market Dynamics?
The leading players in the Anti-Obesity Drugs Market industry are also undergoing product creation and finding market approvals as a result of the rise in the global obesity population. In 2023, Novo Nordisk formed an alliance with Evotec AG to discover and produce drug molecules to treat a variety of metabolic disorders, such as obesity, diabetes, and other related illnesses. The increasing need for medicines that have long-term effects is expected to create enormous opportunities for market vendors to develop new products. This factor is expected to eventually aid the market growth.
Purchase This Comprehensive Report (PDF with Insights, Charts, Tables, and Figures) :https://www.maximizemarketresearch.com/request-sample/100768/
What is the Regional Insights Of Anti-Obesity Drugs Market Expected to grow?
North America is expected to hold a dominant Anti-Obesity Drugs Market market share during the forecast period, owing to the increase in the obese population and high healthcare expenditure are the primary factors driving the market’s growth. The Centres for Disease Control and Prevention (CDC) states that adult obesity prevalence is growing owing to current circumstances of work from home, less physical activity, and financial and other stress among the adult population which contributes to the market growth in the region.
What is the expected growth of Anti-Obesity Drugs Market segmentation?
Based on Drug Type, the Prescription Drugs segment is expected to hold the dominant market share during the forecast period. The easy availability of therapeutically effective anti-obesity drugs in the market is credited with the segment’s rapid growth. The increasing consumption of junk food is causing global population health to deteriorate, leading to an increase in the prevalence of obesity, especially in developing countries.
Get More Information Before Buying:https://www.maximizemarketresearch.com/market-report/global-anti-obesity-drugs-market/100768/
What is Anti-Obesity Drugs Market Segmentation?
by Mechanism of Action
Peripherally Acting Drugs
Centrally Acting Drugs
by Drug Type
Prescription Drugs
OTC Drugs
by Distribution Channel
Hospitals Pharmacies
Retail Pharmacies
E-commerce
What are the key Players for Anti-Obesity Drugs Market?
North America
1. Icahn Enterprises
2. Pfizer
3. Orexigen Therapeutics
4. Bristol-Myers Squibb
Europe
5. Novo Nordisk
6. Roche
7. Norgine
8. GSK
9. Saniona
10. AstraZeneca
11. Hikma Pharmaceuticals
Key Offerings:
- Past Market Size and Competitive Landscape
- Anti-Obesity Drugs Market Size, Share, Size & Forecast by different segment
- Market Dynamics – Growth Drivers, Restraints, Opportunities, and Key Trends by region
- Anti-Obesity Drugs Market Segmentation – A detailed analysis by Product
- Value chain and supply chain analysis
- Legal Aspects of business by region
- Lucrative business opportunities with SWOT analysis
- Recommendations
More Trending Reports by Maximize Market Research –
About Maximize Market Research:
Maximize Market Research is one of the fastest-growing market research and business consulting firms serving clients globally. Our revenue impact and focused growth-driven research initiatives make us a proud partner of majority of the Fortune 500 companies. We have a diversified portfolio and serve a variety of industries such as IT & telecom, chemical, food & beverage, aerospace & defense, healthcare and others.
Contact Maximize Market Research:
MAXIMIZE MARKET RESEARCH PVT. LTD.
⮝ 3rd Floor, Navale IT park Phase 2,
Pune Banglore Highway, Narhe
Pune, Maharashtra 411041, India.
✆ +91 9607365656